K022182 is an FDA 510(k) clearance for the MEDISENSE PRECISION EASYBLOOD GLUCOSE MONITORING SYSTEM, MEDISENSE OPTIUM EASYBLOOD GLUCOSE MONITORING SYSTEM. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).
Submitted by Abbott Laboratories (Bedford, US). The FDA issued a Cleared decision on September 9, 2002, 68 days after receiving the submission on July 3, 2002.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.